Search results
TEVA Q2 Earnings & Sales Top as Austedo Outperforms, Stock Up
Zacks via Yahoo Finance· 9 months agoTeva Pharmaceutical Industries Limited TEVA reported second-quarter 2023 adjusted earnings of 56...
TEVA Beats Q4 Earnings Estimates, Sales Miss & Stock Down
Zacks via Yahoo Finance· 1 year agoTeva Pharmaceutical Industries Limited TEVA reported fourth-quarter 2022 adjusted earnings of 71...
Teva Pharmaceutical: Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 5 months agoTeva Pharmaceutical Industries (NYSE:TEVA) is one of the leading companies in the healthcare sector, specializing in developing and commercializing...
Teva's Migraine Treatment Effective In Patients With Co-Morbid Depression
Benzinga via Yahoo Finance· 2 years agoTeva Pharmaceutical Industries Ltd (NYSE: TEVA) announced the results of two studies presented at...
3 Generic Drug Stocks to Watch Amid Continued Pricing Pressure
Zacks via Yahoo Finance· 2 years agoThe impact of COVID-19 and pricing pressure on the Zacks Medical - Generic Drugs industry persists....
Drug, Biotech Stocks' Q2 Earnings on Jul 27: BMY, GSK & More
Zacks via Yahoo Finance· 2 years agoThe second-quarter 2022 reporting cycle of the Medical sector is currently in full swing. The sector...
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoTeva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2022 Earnings Call Transcript February 8, 2023...
Eli Lilly's Migraine Drug Infringed Teva's Patents, Ordered To Pay $176M
Benzinga via Yahoo Finance· 1 year agoA federal jury has asked Eli Lilly And Company (NYSE: LLY) to pay Teva Pharmaceuticals International...
TEVA Matches Q1 Earnings Estimates, Lowers 2022 Sales View
Zacks via Yahoo Finance· 2 years agoTEVA reports in-line Q1 earnings but misses estimates for sales. It lowers its sales expectations...
Teva Pharma Posts Lower Q4 Earnings, FY23 Outlook Within Expectations
Benzinga via Yahoo Finance· 1 year agoTeva Pharmaceutical Industries Ltd's (NYSE: TEVA) Q4 sales reached $3.88 billion, shrinking 5% Y/Y,...